Articles Tagged With: Dementia
-
Active Life, Healthy Mind
Daily exercise, frequent social interactions, and even performing regular household chores can lower dementia risk.
-
Risk Factors Associated with Alzheimer’s Disease and Related Dementias in the United States
Two independent analyses of U.S. national surveys support evidence that targeted risk-reduction strategies may reduce the burden of Alzheimer’s disease in the population.
-
Thyroid Problems Could Raise Dementia Risk
Researchers recently observed an association between hypothyroidism and dementia.
-
Examining the Relationship Between Sleep in Middle Age and Dementia Development
This long-term study revealed people who reported sleeping an average of seven hours or less nightly at age 50 years and 60 years were 30% more likely to develop dementia than their counterparts who reported sleeping seven hours or more.
-
Social Isolation Can Raise Dementia Risk
These patients exhibited lower volume in brain gray matter in various regions associated with learning and thinking.
-
Major Traumatic Brain Injury Can Raise Dementia Risk
Patients with brain bleeding and a long hospital stay were 1.5 times more likely to develop dementia compared to those with no injury.
-
Donepezil Transdermal Patch (Adlarity)
Donepezil transdermal system can be prescribed to treat mild, moderate, and severe dementia of the Alzheimer’s type.
-
Your Brain on COVID: Damage Found in Two New Studies
Dementia and other adverse effects on the brain are occurring in some COVID-19 survivors, an ominous finding for the millions infected — even those with only mild symptoms, according to two new studies.
-
Dementia Model Can Help Patients with Alzheimer’s
Patients with dementia face barriers to care, particularly for underserved communities. One possible solution is a community-based partnership approach and expansion of existing institutional and local resources. -
Plasma Biomarkers for Neurodegenerative Dementias: We Are Getting Closer
Two recent multicenter studies suggest that plasma biomarkers, including phosphorylated-tau181, could be used as cost-effective and more readily accessible biomarkers for the diagnosis and management of individuals with neurodegenerative dementias.